Bicara Therapeutics (BCAX) IPO deck
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing tumor-targeting biologics that harness the tumor microenvironment for durable cancer treatments.
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing tumor-targeting biologics that harness the tumor microenvironment for durable cancer treatments.
%20IPO%20deck){kind=link}